Lux Biosciences, Inc. - Product Pipeline Analysis by GlobalData

VIEWS: 17 PAGES: 23

More Info
									                                            Lux Biosciences, Inc. - Product Pipeline Analysis
     Reference Code: GDME14725PD                                                                                           Publication Date: NOV 2010



     Company Snapshot                                              Company Overview
     Key Information
                                                                   Lux Biosciences, Inc. (Lux Biosciences) is a biotechnology company,
      Lux Biosciences, Inc., Key Facts                             engaged in the development and marketing of medical devices for the
                                                                   ophthalmic markets. The company develops LX series silicone matrix
      Web Address                            www.luxbio.com
                                                                   ocular implants for the prevention of rejection in corneal transplantation.
      Turnover (in USD Million)              0.20                  Lux Biosciences develops product-enabling bio-erodible polymer
                                                                   technologies, which facilitate targeted and sustained delivery of molecules
      Number of Employees                    2                     to the eye. Its LX201 is cyclosporine A (CsA) eluting silicone matrix implant
      Industry                               Pharmaceuticals and   useful for the release of cyclosporine A (CsA) locally to the eye, to prevent
                                             Healthcare-           rejection by cornea transplant recipients.
      Source:Primary / Secondary Research
      GlobalData



     Lux Biosciences, Inc. Pipeline Products

     Lux Biosciences, Inc. Key Pipeline Products by                Lux Biosciences, Inc. Key Pipeline Products by Therapy Area
     Equipment Type
     Equipment Type                         No of Products         Therapy Area                                                 No of Products
     Niche technologies                            1               Blepharitis, Dry eye                                                1
                                                                   Corneal diseases                                                     1
     Source: Primary / Secondary Research                          Source: Primary / Secondary Research
     GlobalData                                                    GlobalData




      Lux Biosciences, Inc. Key Pipeline Products by Development Stage

     Developmental Stage                                                                                  No of Products
     Clinicals                                                                                                   1
     Pre-Clinicals                                                                                              4
     Early development                                                                                          -
     Source: Primary / Secondary Research
     GlobalData
     Note : (-) indicates 'Not Available'



      Lux Biosciences, Inc. Key Pipeline Products by Trial Phase

     Trial Phase                                                                                          No of Products
     Phase IV                                                                                                   -
     Phase III                                                                                                  1
     Phase II                                                                                                   -
     Phase I                                                                                                    -
     Source: Primary / Secondary Research
     GlobalData
     Note : (-) indicates 'Not Available'




Lux Biosciences, Inc. - Product Pipeline Analysis                                                                             Reference Code: GDME14725PD

Source : www.globalcompanyintelligence.com                                                                                                              Page 1
     Table of Contents
     Table of Contents................................................................................................................................................................................................................................................................... 2
     List of Tables .......................................................................................................................................................................................................................................................................... 3
     List of Figures......................................................................................................................................................................................................................................................................... 3
     Key Facts ............................................................................................................................................................................................................................................................................... 4
     Lux Biosciences, Inc. - Major Products and Services ............................................................................................................................................................................................................ 5
           Lux Biosciences, Inc. Pipeline Products by Equipment Type .......................................................................................................................................................................................... 6
           Lux Biosciences, Inc. Pipeline Products by Development Stage .................................................................................................................................................................................... 8
           Lux Biosciences, Inc. Pipeline Products by Therapy Area ............................................................................................................................................................................................ 10
           Lux Biosciences, Inc. Pipeline Products by Trial Phase ................................................................................................................................................................................................ 12
           LUMITECT..................................................................................................................................................................................................................................................................... 14
                 Product Status......................................................................................................................................................................................................................................................... 14
                 Product Description ................................................................................................................................................................................................................................................. 14
                 Product Milestone ................................................................................................................................................................................................................................................... 14
                 LUMITECT Clinical Trial.......................................................................................................................................................................................................................................... 15
           LX212 Ocular Implant .................................................................................................................................................................................................................................................... 18
                 Product Status...............................................................................................................................
								
To top